REFERENCES
- Jacobs R. A. General problems in infectious diseases—infections in drug users. Current Medical Diagnosis and Treatment, L. M. Tierney, S. J. McPhee, M. A. Papadakis. Appleton and Lange, Stamford, Connecticut 1997; 1163–1166
- Centers for Disease Control and Prevention, Recommendations for prevention and control of hepatitis C (HCV) infection and HCV-related chronic disease. MMWR Morb. Mortal Wkly. Rep October 16, 1998; 47: 1–39
- Lee W. M. Hepatitis B virus infection. N. Engl. J. Med 1997; 337(24)1733–1745
- Chang M. H., Chien J. C., Lai M. S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med 1997; 336(26)1855–1859
- National Institute of Health Development Conference Panel Statement, Management of hepatitis C. Hepatology 1997; 26(3, suppl. 1)25–105
- Marwick C. Hepatitis C is focus of NIH Consensus Panel. JAMA 1997; 227(16)1268–1269
- Feinman S. V., Berris B., Bojraski S. Posttransfusion hepatitis in Toronto, Canada. Gastroenterology 1998; 95: 464–469
- Metzger D. S., Woody P. E., McLellan A. T., et al. Human immunodeficiency virus seroconversion among intravenous drug users in-and-out-of-treatment: an 18 month prospective follow up. J. Acquir. Immune Defic. Syndr. 1994; 7: 190–198